Geode Capital Management’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Buy |
36,678
+24,901
| +211% | +$176K | ﹤0.01% | 3884 |
|
|
2026
Q1 | $120K | Buy |
11,777
+6,149
| +109% | +$58.2K | ﹤0.01% | 4088 |
|
|
2025
Q4 | $39.8K | Buy |
5,628
+2,409
| +75% | +$27.5K | ﹤0.01% | 4273 |
|
|
2025
Q3 | $41.8K | Buy |
3,219
+263
| +9% | +$3.91K | ﹤0.01% | 4329 |
|
|
2025
Q2 | $53.2K | Sell |
2,956
-133
| -4% | -$2.66K | ﹤0.01% | 4203 |
|
|
2025
Q1 | $66.9K | Buy |
3,089
+440
| +17% | +$9.12K | ﹤0.01% | 4136 |
|
|
2024
Q4 | $49.9K | Sell |
2,649
-101
| -4% | -$2.98K | ﹤0.01% | 4244 |
|
|
2024
Q3 | $101K | Buy |
2,750
+296
| +12% | +$9.08K | ﹤0.01% | 4100 |
|
|
2024
Q2 | $60K | Buy |
2,454
+342
| +16% | +$17.1K | ﹤0.01% | 4243 |
|
|
2024
Q1 | $136K | Buy |
2,112
+276
| +15% | +$20.9K | ﹤0.01% | 4058 |
|
|
2023
Q4 | $227K | Hold |
1,836
| – | – | ﹤0.01% | 3894 |
|
|
2023
Q3 | $243K | Buy |
1,836
+204
| +13% | +$31.6K | ﹤0.01% | 3906 |
|
|
2023
Q2 | $300K | Hold |
1,632
| – | – | ﹤0.01% | 3858 |
|
|
2023
Q1 | $274K | Hold |
1,632
| – | – | ﹤0.01% | 3902 |
|
|
2022
Q4 | $352K | Buy |
1,632
+13
| +0.8% | +$4.91K | ﹤0.01% | 3831 |
|
|
2022
Q3 | $626K | Sell |
1,619
-79
| -5% | -$44.8K | ﹤0.01% | 3610 |
|
|
2022
Q2 | $714K | Sell |
1,698
-1,089
| -39% | -$526K | ﹤0.01% | 3570 |
|
|
2022
Q1 | $1.66M | Buy |
2,787
+42
| +2% | +$31.2K | ﹤0.01% | 3356 |
|
|
2021
Q4 | $3.04M | Buy |
2,745
+39
| +1% | +$84.8K | ﹤0.01% | 3163 |
|
|
2021
Q3 | $10.4M | Sell |
2,706
-10
| -0.4% | -$31.5K | ﹤0.01% | 2435 |
|
|
2021
Q2 | $7.82M | Buy |
2,716
+404
| +17% | +$954K | ﹤0.01% | 2632 |
|
|
2021
Q1 | $4.62M | Buy |
2,312
+1,105
| +92% | +$1.66M | ﹤0.01% | 2827 |
|
|
2020
Q4 | $1.15M | Buy |
1,207
+336
| +39% | +$287K | ﹤0.01% | 3326 |
|
|
2020
Q3 | $697K | Buy |
871
+48
| +6% | +$42.7K | ﹤0.01% | 3325 |
|
|
2020
Q2 | $781K | Buy |
823
+612
| +290% | +$612K | ﹤0.01% | 3225 |
|
|
2020
Q1 | $188K | Buy |
211
+54
| +34% | +$44.2K | ﹤0.01% | 3571 |
|
|
2019
Q4 | $84K | Hold |
157
| – | – | ﹤0.01% | 4006 |
|
|
2019
Q3 | $67K | Hold |
157
| – | – | ﹤0.01% | 4024 |
|
|
2019
Q2 | $80K | Hold |
157
| – | – | ﹤0.01% | 4002 |
|
|
2019
Q1 | $77K | Hold |
157
| – | – | ﹤0.01% | 3945 |
|
|
2018
Q4 | $67K | Hold |
157
| – | – | ﹤0.01% | 3939 |
|
|
2018
Q3 | $91K | Buy |
+157
| New | +$95.8K | ﹤0.01% | 3952 |
|
Other funds holding PAVM
TSC
SS
Geode Capital Management's PAVM Position: Q2 2026 in Review
Geode Capital Management increased its PAVmed (PAVM) stake by 211% in Q2 2026, buying an estimated $176K and bringing the position to 36,678 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #3884.
Geode Capital Management first reported a position in PAVM in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.4M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.
- Geode Capital Management held 36,678 shares of PAVmed worth $218K as of Q2 2026.
- Geode Capital Management bought 24,901 PAVmed shares in Q2 2026, an estimated $176K.
- PAVmed made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3884 holding.
- Geode Capital Management first reported a position in PAVmed in Q3 2018 and has held it in 32 quarters since.
- Geode Capital Management's PAVmed position peaked at $10.4M in Q3 2021.
- 20 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.